NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes.
Gong ZC, Huang Q, Dai XP, Lei GH, Lu HB, Yin JY, Xu XJ, Qu J, Pei Q, Dong M, Zhou BT, Shen J, Zhou G, Zhou HH, Liu ZQ.
Gong ZC, et al. Among authors: zhou g, zhou bt, zhou hh.
Br J Clin Pharmacol. 2012 Sep;74(3):501-9. doi: 10.1111/j.1365-2125.2012.04202.x.
Br J Clin Pharmacol. 2012.
PMID: 22296034
Free PMC article.
Clinical Trial.